Literature DB >> 14567537

Factor VII deficiency.

David J Perry1.   

Abstract

As yet, there have been neither systematic reviews nor reports of randomized, controlled trials involving factor VII (FVII) deficiency. Hence, a picture of this disorder can only be drawn by reviewing and summarizing the data that is available. This article provides an overview of the understanding of this rare, inherited disorder of coagulation. In particular, the status of current knowledge of the disorder's prevalence, clinical presentation, diagnostic characteristics and molecular genetics is reviewed, followed by a summary of currently available options for its treatment and management.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14567537     DOI: 10.1097/00001721-200306001-00012

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  4 in total

Review 1.  Recombinant factor VIIa (Eptacog Alfa): a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders.

Authors:  M Asif A Siddiqui; Lesley J Scott
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Recombinant factor VIIa: a review on its clinical use.

Authors:  Massimo Franchini
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

Review 3.  Novel heterozygous F7 gene mutation (c. C1286T) associated with congenital factor VII deficiency: A case report and literature review.

Authors:  Hua Tang; Xingzhao Luan; Jiaqi Li; Gen Jiang; Haowen Zhen; Hao Li; Wei Xiang; Jie Zhou
Journal:  J Clin Lab Anal       Date:  2022-03-29       Impact factor: 2.352

Review 4.  Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic.

Authors:  Shilpa Jain; Jennifer Donkin; Mary-Jane Frey; Skye Peltier; Sriya Gunawardena; David L Cooper
Journal:  J Blood Med       Date:  2018-11-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.